comparemela.com

Latest Breaking News On - Clearmind medicine inc stock exchange - Page 1 : comparemela.com

Clearmind Medicine and SciSparc to Conduct Study Evaluating Combination Treatment for Obesity and Metabolic Syndrome

The treatment combines Clearmind s MEAI, a novel proprietary psychedelic treatment for various addictions, and SciSparc s Palmitoylethanolamide , the active ingredient of its proprietary. | June 16, 2023

Clearmind Medicine : Condensed Interim Consolidated Financial Statements - Form 6-K

Clearmind Medicine Announces First US Site for its Phase I/IIa Clinical Trial Evaluating CMND-100 in Patients with Alcohol Use Disorder

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.